Murry W. Wynes

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Archives of Pathology & Laboratory Medicine · 2018 · 887 citations · Full text

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr, Mark Kockx et al. · Journal of Thoracic Oncology · 2018 · 793 citations · Full text

Real-life Clinical Samples, Biomarker (Medicine), Translational Medicine +12

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 615 citations · Full text

Oncology, Medicine, Bronchial Neoplasm +8

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Molecular Diagnostics · 2018 · 333 citations · Full text

Oncology, Medicine, Bronchial Neoplasm +8

From Expert Review of Molecular Diagnostics

Céline Mascaux, Nir Peled, Kavita Garg et al. · 2010 · 283 citations

Advanced Lung Disease, Lethal Cancer, Diagnosis +27